ื‘ื“ื™ืงืช ื‘ื™ื•ืคืกื™ื” ื ื•ื–ืœื™ืช Guardant Reveal ืœื–ื™ื”ื•ื™ ืฉืืจื™ืช ืžื—ืœื” ืžื™ื ื™ืžืœื™ืช (MRD) โ€“ ืฉืืœื•ืช ื•ืชืฉื•ื‘ื•ืช

ืžื”ื™ ื‘ื“ื™ืงืช Guardant Reveal?

ื‘ื“ื™ืงืช Guardant Reveal ื”ื™ื ื‘ื“ื™ืงื” ื’ื ื•ืžื™ืช ืžื‘ื•ืกืกืช ื‘ื™ื•ืคืกื™ื” ื ื•ื–ืœื™ืช, ื”ืžืกืคืงืช ืžื™ื“ืข ื”ืื ืงื™ื™ืžืช ืฉืืจื™ืช ืžื—ืœื” ืžื™ื ื™ืžืœื™ืช (MRD) – Minimal Residual Disease , ื•ืžื™ื•ืขื“ืช ืœื—ื•ืœื™ื ืฉืื•ื‘ื—ื ื• ืขื ืกืจื˜ืŸ ืฉื“, ืจื™ืื•ืช ืื• ืžืขื™ ื’ืก ืœืื—ืจ ื ื™ืชื•ื— ืœื”ืกืจืช ื”ื’ื™ื“ื•ืœ ื•/ืื• ืœืื—ืจ ื˜ื™ืคื•ืœ ืžืฉืœื™ื. ื‘ื‘ื“ื™ืงื” ืžื‘ื•ื“ื“ื™ื ืืช ื”ื“ื "ื ื”ื—ื•ืคืฉื™ ื”ืžื•ืคืจืฉ ืœื–ืจื ื”ื“ื ื‘ื™ืŸ ื”ืฉืืจ ืžืชืื™ ื”ื’ื™ื“ื•ืœ ื•ืžื‘ืฆืขื™ื ืกืจื™ืงื” ืงืคื“ื ื™ืช ืœืื™ืชื•ืจ ืฉื™ื ื•ื™ื™ื (ืžื•ื˜ืฆื™ื•ืช) ื‘ื’ื ื™ื ื•ื‘ืจืžื•ืช ื”ืžืชื™ืœืฆื™ื” ื”ื ืžืฆืื™ื ื‘ืฉื›ื™ื—ื•ืช ื ืžื•ื›ื” ื•ืžืืคื™ื™ื ื™ื ื“ื "ื ืฉื”ื•ืคืจืฉ ืžื”ื’ื™ื“ื•ืœ ืœื–ืจื ื”ื“ื.

ืœืžื™ ืžืชืื™ืžื” ื‘ื“ื™ืงืช Guardant Reveal?

ื‘ื“ื™ืงืช Guardant Reveal ืžืชืื™ืžื” ืœืžื˜ื•ืคืœื™ื ืฉืื•ื‘ื—ื ื• ืขื ื’ื™ื“ื•ืœ ื‘ืžืขื™ ื”ื’ืก, ืจื™ืื•ืช ืื• ืฉื“ย  ืœืื—ืจ ื ื™ืชื•ื— ืœื”ืกืจืช ื”ื’ื™ื“ื•ืœ ื•/ืื• ืœืื—ืจ ื˜ื™ืคื•ืœ ืžืฉืœื™ื.ย 

ื›ื™ืฆื“ ื”ื‘ื“ื™ืงื” ื™ื›ื•ืœื” ืœืกื™ื™ืข ืœื™?

ื‘ื“ื™ืงืช Guardant Reveal ืžืกื™ื™ืขืช ืœื—ื•ืœื™ื ืฉืื•ื‘ื—ื ื• ืขื ืกืจื˜ืŸ ืžืขื™ ื”ื’ืก, ืฉื“ ืื• ืจื™ืื•ืช ืœืขื ื•ืช ืขืœ ื”ืฉืืœื” ื”ืื ืงื™ื™ืžืช ืฉืืจื™ืช ืžื—ืœื” ืžื™ื ื™ืžืœื™ืช (MRD) ืœืื—ืจ ื ื™ืชื•ื— ื•/ืื• ืœืื—ืจ ื˜ื™ืคื•ืœ ืžืฉืœื™ื ื‘ื›ื“ื™ ืœื—ื–ื•ืช ืืช ื”ืกื™ื›ื•ืŸ ืœื”ื™ืฉื ื•ืช ืžื•ืงื“ืžืช ืฉืœ ื”ืžื—ืœื” ื•ื‘ื›ืš ืœืชื›ื ืŸ ืืช ื”ืžืฉืš ื”ื˜ื™ืคื•ืœ ื‘ืฆื•ืจื” ืื•ืคื˜ื™ืžืœื™ืช.

ื›ื™ืฆื“ ืžืชื‘ืฆืขืช ื”ื‘ื“ื™ืงื”?

ื”ื‘ื“ื™ืงื” ืžืชื‘ืฆืขืช ืขืœ ื“ื’ื™ืžืช ื“ื ืœืœื ืฆื•ืจืš ื‘ืจืงืžื” ื‘ื›ื“ื™ ืœืกืคืง ืžื™ื“ืข ืžื”ื™ืจ ืื•ื“ื•ืช ื ื•ื›ื—ื•ืช ืฉืืจื™ืช ืžื—ืœื” ืžื™ื ื™ืžืœื™ืช.

ืžื”ืŸ ื™ืชืจื•ื ื•ืชื™ื” ืฉืœ ื‘ื“ื™ืงืช ื‘ื™ื•ืคืกื™ื” ื ื•ื–ืœื™ืช?

ื‘ื“ื™ืงืช Guardant Reveal ืžืกืคืงืช ืžื™ื“ืข ืžื“ื•ื™ืง ื•ืžื”ื™ืจ ืื•ื“ื•ืช ื ื•ื›ื—ื•ืช ืฉืืจื™ืช ืžื—ืœื” ืžื™ื ื™ืžืœื™ืช MRD ืœื—ื•ืœื™ื ืฉืื•ื‘ื—ื ื• ืขื ืกืจื˜ืŸ ืฉื“, ืจื™ืื•ืช ืื• ืžืขื™ ื’ืก ื‘ื›ื“ื™ ืœื—ื–ื•ืช ืืช ื”ืกื™ื›ื•ืŸ ืœื”ื™ืฉื ื•ืช ืžื•ืงื“ืžืช ื‘ื”ืฉื•ื•ืื” ืœื›ืœื™ื ื”ืžืงื•ื‘ืœื™ื ื›ื™ื•ื, ื›ื’ื•ืŸ ื”ื“ืžื™ื•ืช ื•ืจืžืช ื—ืœื‘ื•ืŸ ื”- Carcinoembryonic Antigen (CEA). ืžื™ื“ืข ื–ื” ื™ื›ื•ืœ ืœืกื™ื™ืข ื‘ืงื‘ืœืช ื”ื—ืœื˜ื” ื”ืื ื•ืื™ื–ื” ื˜ื™ืคื•ืœ ืžืฉืœื™ื ื™ืกื™ื™ืข ืœืžื˜ื•ืคืœ.

ืžื” ืžื™ื™ื—ื“ ืืช ื‘ื“ื™ืงืช Guardant Reveal?

ืงื™ื™ืžื•ืช ื‘ื“ื™ืงื•ืช ืฉื•ื ื•ืช ืœื–ื™ื”ื•ื™ ืฉืืจื™ืช ืžื—ืœื” ืžื™ื ื™ืžืœื™ืช MRD ืฉืžืงื•ืจื• ืžื“ื "ื ื’ื™ื“ื•ืœื™ ื—ื•ืคืฉื™ ื‘ื“ื. ืขื ื–ืืช ื‘ื“ื™ืงืช Guardant Reveal ื”ื™ื ื” ื”ื‘ื“ื™ืงื” ื”ื™ื—ื™ื“ื” ื”ืžื‘ื•ืกืกืช ืขืœ ื“ื’ื™ืžืช ื“ื ื‘ืœื‘ื“ ืœืœื ืฆื•ืจืš ื‘ืจืงืžืช ื’ื™ื“ื•ืœ ื•ืœื›ืŸ ืžืกืคืงืช ืชื•ืฆืื•ืช ืžื“ื•ื™ืงื•ืช ื‘ื–ืžืŸ ื”ืžื”ื™ืจ ื‘ื™ื•ืชืจ.
ื—ื‘ืจืช Guardant Health ืžืคืชื—ืช ื”ื‘ื“ื™ืงื” ื”ื™ื ื” ื—ืœื•ืฆื” ื‘ืชื—ื•ื ื‘ื“ื™ืงื•ืช ื’ื ื•ืžื™ื•ืช ืžื‘ื•ืกืกื•ืช ื‘ื™ื•ืคืกื™ื” ื ื•ื–ืœื™ืช ื•ืžืื’ืจื™ ื”ืžื™ื“ืข ืฉืขืœื™ื”ื ืžืกืชืžื›ืช ื”ืžืขื‘ื“ื” ื”ื™ื ื ื”ืžืงื™ืคื™ื ื•ื”ืžืชืงื“ืžื™ื ื‘ื™ื•ืชืจ ื‘ืขื•ืœื.

Guardant Reveal - Oncotest

ืฉื•ื—ื—ื• ืขื ื”ืจื•ืคื ื”ืžื˜ืคืœ ืฉืœื›ื ืื•ื“ื•ืช ื‘ื“ื™ืงื” ืœื–ื™ื”ื•ื™ ืฉืืจื™ืช ืžื—ืœื” ืžื™ื ื™ืžืœื™ืช ืœืื—ืจ ื ื™ืชื•ื— ืœืฆื•ืจืš ืงื‘ืœืช ื”ื—ืœื˜ื” ืžื•ืฉื›ืœืช ืขืœ ืืคืฉืจื•ื™ื•ืช ื˜ื™ืคื•ืœ ื”ืขื•ืžื“ื•ืช ืœืจืฉื•ืชืš.
ื—ื‘ืจืช ืื•ื ืงื•ื˜ืกื˜ ืžืฆื™ืขื” ืืช ื”ื‘ื“ื™ืงื•ืช ื”ื’ื ื•ืžื™ื•ืช ื”ืžืงื™ืคื•ืช ื•ื”ืžืชืงื“ืžื•ืช ืœืกืจื˜ืŸ, ื‘ื™ื ื™ื”ืŸ ืืช ื‘ื“ื™ืงื” ื’ื ื•ืžื™ืช Guardant Reveal ืžื‘ื•ืกืกืช ื‘ื™ื•ืคืกื™ื” ื ื•ื–ืœื™ืช ืฉืœ ื—ื‘ืจืช Guardant Health.ย 
Guardant Reveal ื”ื™ื ื” ื‘ื“ื™ืงื” ื’ื ื•ืžื™ืช ืคื•ืจืฆืช ื“ืจืš ืžื‘ื•ืกืกืช ื‘ื™ื•ืคืกื™ื” ื ื•ื–ืœื™ืช ื”ืžื™ื•ืขื“ืช ืœื—ื•ืœื™ื ืฉืื•ื‘ื—ื ื• ืขื ืกืจื˜ืŸ ืžืขื™ ื”ื’ืก, ืฉื“ ืื• ืจื™ืื•ืช .
ื”ืžื™ื“ืข ื”ืžืชืงื‘ืœ ืžื”ื‘ื“ื™ืงื” ืžืืคืฉืจ ืœื–ื”ื•ืช ื”ืื ืงื™ื™ืžืช ืฉืืจื™ืช ืžื—ืœื” ืžื™ื ื™ืžืœื™ืช ื‘ื›ื“ื™ ืœืกื™ื™ืข ื‘ืงื‘ืœืช ื”ื—ืœื˜ื” ื˜ื™ืคื•ืœื™ืช ืžื™ื˜ื‘ื™ืช ืœืžื˜ื•ืคืœ.

ื“ื‘ืจื• ืื™ืชื ื•

ืืชื ืœื ืœื‘ื“! ื ืฆื™ื’ื™ ื”ืฉื™ืจื•ืช ืฉืœื ื• ืขื•ืžื“ื™ื ืœืจืฉื•ืชื›ื ื‘ืฉืขื•ืช ืคืขื™ืœื•ืช ื”ืžืขื ื” ื‘ื™ืžื™ื ื'-ื”' ื‘ื™ืŸ ื”ืฉืขื•ืช 08:00-17:00, ืื ื ืžืœืื• ืืช ื”ืคืจื˜ื™ื ื•ื ื—ื–ื•ืจ ืืœื™ื›ื ื‘ื”ืงื“ื.

ื“ื‘ืจื• ืื™ืชื ื•

ืืชื ืœื ืœื‘ื“! ื ืฆื™ื’ื™ ื”ืฉื™ืจื•ืช ืฉืœื ื• ืขื•ืžื“ื™ื ืœืจืฉื•ืชื›ื ื‘ืฉืขื•ืช ืคืขื™ืœื•ืช ื”ืžืขื ื” ื‘ื™ืžื™ื ื'-ื”' ื‘ื™ืŸ ื”ืฉืขื•ืช 08:00-17:00, ืื ื ืžืœืื• ืืช ื”ืคืจื˜ื™ื ื•ื ื—ื–ื•ืจ ืืœื™ื›ื ื‘ื”ืงื“ื.